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Global Trends in Typhoidal Salmonellosis: A Systematic Review
Daina Als,1 Amruta Radhakrishnan,1 Paul Arora,2 Michelle F. Gaffey,1 Susan Campisi,1 Russanthy Velummailum,1 Farhana Zareef,1
and Zulﬁqar A. Bhutta1,2,3*
1

Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada; 2Dalla Lana School of Public Health, University of Toronto,
Toronto, Canada; 3Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan

Abstract. Typhoid and paratyphoid fever continue to signiﬁcantly contribute to global morbidity and mortality. Disease
burden is higher in low-and middle-income settings where surveillance programs are rare and little systematic information
exists at population level. This review evaluates national, regional, and global trends in the incidence of typhoid fever and of
related morbidity and mortality. A literature search in Medline, Embase, and Web of Science was conducted in June 2016,
followed by screening and data extraction in duplicate. Studies reporting blood culture estimates of typhoid or paratyphoid
morbidity and mortality were included in the analysis. Our search yielded 5,563 unique records, of which 1978 were assessed
for relevance with 219 records meeting the eligibility criteria. Salmonella enterica serotype Typhi was the most commonly
reported organism (91%), with the occurrence of typhoidal Salmonella (either incidence or prevalence) being the most commonly reported outcome (78%), followed by typhoid fever mortality, ileal perforation morbidity, and perforation mortality,
respectively. Fewer than 50% of studies stratiﬁed outcomes by age or urban/rural locality. Surveillance data were available
from 29 countries and patient-focused studies were available from 32 countries. Our review presents a mixed picture with
declines reported in many regions and settings but with large gaps in surveillance and published data. Regional trends show
generally high incidence rates in South Asia, sub-Saharan Africa, and East Asia and Paciﬁc where the disease is endemic in
many countries. Signiﬁcant increases have been reported in certain countries but should be explored in the context of longterm trends and underlying at-risk populations.

Typhoid and paratyphoid fever transmission occurs
through ingestion of water or food contaminated with
typhoidal Salmonella bacteria, with asymptomatic carriers
playing an important role in contamination and onward
transmission.4 Risk factors for typhoid fever include poverty;
overcrowding; poor status of water, sanitation, and hygiene
(WASH) infrastructure; and poor food-handling practices
(Figure 1). Recent estimates suggest that 13% of the global
population is living in extreme poverty (deﬁned as people living
on less than $1.90/day),5 with poverty rates being as high as
60% in some countries,5 with deﬁcient WASH infrastructure in
many of these settings and some one billion people still
practicing open defecation globally.6 Despite the persistence
of risk factors in many settings, there is a general perception
that the burden of typhoid fever has reduced globally, given
overall economic growth and development. However, estimates from the 2015 GBD Study suggest that disabilityadjusted life years (DALYs) caused by typhoid remain greater
than 200 DALYs per 100,000 population in countries across
Africa and South Asia, including as many as 587.99 DALYs
and 556.88 DALYs per 100,000 population in Burkina Faso
and Bangladesh, respectively.7 The burden in both countries
remains high compared with that in 2010, when 550.24 DALYs
were attributable to typhoid in Burkina Faso and 689.91
DALYs in Bangladesh.7
Given the continuing importance of typhoid as a public
health problem in many settings, we undertook a systematic
review of global literature and data to evaluate national, regional, and global trends in the incidence and prevalence of
typhoid and paratyphoid fever and related morbidity and
mortality in recent decades (1990–2016).

INTRODUCTION
Typhoid and paratyphoid fever, collectively known as enteric
fever, are systemic infections caused by the human-adapted
pathogens Salmonella enterica serotype Typhi (S. Typhi) and
Salmonella enterica serotype Paratyphi (S. Paratyphi) A, B, and
C.1 Enteric fever continues to be a signiﬁcant contributor to global
morbidity and mortality with an estimated 26.9 million cases
and approximately 200,000 deaths directly or indirectly attributable to typhoid each year as of 2010.1 According to recent estimates, low-and middle-income countries (LMICs)
contribute to almost half of the morbidity and mortality rates of
typhoid and paratyphoid fever at 11.9 million cases and
129,000 deaths, respectively.2 Similarly, modeled data from
the Global Burden of Disease (GBD) Study conducted by the
Institute for Health Metrics and Evaluation estimate typhoid
and paratyphoid fever morbidity at approximately 15.5 million
with 154,000 deaths in 2016.3 However, these estimates rely on
a modeling approach and given the heterogeneity in terms of
diagnostic tools and resource limitations, signiﬁcant underestimation of disease burden might be occurring. Typhoid and
paratyphoid fever can be treated with appropriate antibiotics;
however, resistance to ﬁrst- and second-line antibiotics is a
growing public health concern. Effective preventive vaccines
exist, and new vaccines are being developed, but corresponding
investments in safe drinking water and sanitation infrastructure,
food safety, and improved living conditions are insufﬁcient.
There are virtually no surveillance programs for typhoid in most
LMICs; hence, little systematic information exists on incidence
and burden at the population level over time. For a disease as
common as enteric fever, such information is essential to guide
policy for targeted prevention and control strategies.

METHODS

* Address correspondence to Zulﬁqar A. Bhutta, Centre for Global
Child Health, The Hospital for Sick Children, Toronto, ON M5G 0A4,
Canada, E-mail: zulﬁqar.bhutta@sickkids.ca or Center of Excellence
in Women and Child Health, The Aga Khan University, Karachi,
Pakistan, E-mail: zulﬁqar.bhutta@aku.edu.

Search strategy. To capture all of the relevant peer-reviewed
literature on typhoid trends, we applied comprehensive search
syntax in multiple electronic databases (Supplemental Appendix
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FIGURE 1. Conceptual framework of typhoid. The conceptual framework describes the environmental and individual-level contextual factors that
inﬂuence typhoid and paratyphoid fever transmission. It shows the common preventative and curative interventions as well as their delivery
platforms and barriers and enablers. It also presents the expected outcomes when control measures are implemented effectively. This ﬁgure
appears in color at www.ajtmh.org.

1). The search syntax combined terms relating to typhoid with
terms relating to trends, longitudinal data, or surveillance. We
searched Medline, Embase, and Web of Science, with no language or date restrictions, in June 2016. We, in addition,
searched the gray literature, including conference proceedings,
medical textbooks, and government surveillance reports. This
was carried out in Google Scholar by modifying the original
search syntax. Conference proceedings were obtained from The
Coalition against Typhoid for nine international typhoid conferences spanning 1984–2015, and we retrieved relevant chapters
on the subject area in standard textbooks of infectious diseases.
We searched for government surveillance reports through
websites including Ministries of Health, Centers for Disease
Control, and Sabin, among others for all countries. To help ensure, we captured all relevant studies and reports, we scanned
the reference lists of the 10 most recent relevant systematic
review articles, and we contacted experts in typhoid research for
any additional items not identiﬁed by our other search methods.
Eligibility. For a study or report to be eligible for inclusion in
our review, it had to 1) report on blood culture–conﬁrmed typhoid or paratyphoid fever; 2) report data from a period of at
least 18 months, to account for any seasonality; and 3) report a
valid population denominator (i.e., total population or total
blood cultures), to allow for quantitative comparisons across
time, populations, and settings. The one exception to the
aforementioned criteria was the inclusion of government
surveillance reports from national disease notiﬁcation
systems which sometimes incorporated other diagnostic

methods such as serological testing and stool cultures. These
data are presented as crude incidences and were included
under the assumption that notiﬁcation systems would use the
reference standard for diagnosis available nationally. Eligible
populations included the general population, hospitalized
patients, and ambulatory care patients. Studies and reports
focusing on a subpopulation with a preexisting morbidity (e.g.,
human immunodeﬁciency virus [HIV], asthma, and cancer)
were excluded. We also excluded studies or reports focusing
on populations in which speciﬁc interventions had been
evaluated (e.g., vaccines, WASH, or behavior change interventions); however, data from control arms of vaccine trials
were included if the study was otherwise eligible. Our main
goal was to assess changing incidence and prevalence trends
of enteric fever in recent decades in endemic countries. For
studies and reports from LMICs, we included only those
published from 1990 onward, to assess recent trends. Robust,
systematic blood culture data on enteric fever are scarce in
developing countries before 1990 because of a lack of resources for surveillance, diagnosis, and treatment; hence, we
focused on 1990 onward where data collection was more
robust. This cutoff was put in place to capture the most recent
culture-conﬁrmed data and the effects of earlier interventions
implemented in the 1970s and 1980s that would begin to show
their effects in the early 1990s. This time period also aligns with
the Millennium Development Goals, allowing for potential
comparisons with gains in maternal and child health. This
relatively recent time period could also take into account
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advances in microbiological testing methodologies in these
settings. At present, most typhoid and paratyphoid cases in
high-income countries (HICs) are imported through travel; we
thus applied no date restriction for inclusion of studies from
HICs because historical data from these countries are needed
to describe longitudinal typhoid trends. Initially, we extracted
data on imported cases of enteric fever in HICs, but chose to
exclude these studies during the synthesis phase as they do
not shed light on disease trends and tend to remain quite low
consistently. Finally, we restricted eligibility to studies or reports published or translated into English, as we did not have
the capacity to systematically assess non-English texts.
The titles and abstracts of the records identiﬁed through our
peer-reviewed and gray literature searches were screened for
potential eligibility in duplicate; we then screened the full-text
publications of those determined to be potentially eligible, also
in duplicate. Screening was completed using Covidence
software.8
Outcomes. We included four outcomes in our review: 1) the
frequency of blood culture–conﬁrmed S. Typhi and S. Paratyphi A, B, or C infection; 2) the frequency of typhoid ileal
perforation; 3) the frequency of death from typhoid or paratyphoid fever; and 4) the frequency of deaths from typhoid ileal
perforation. We extracted and derived several measures of
these outcomes for our analyses, described in the following
paragraph.
Data extraction. Data from eligible peer-reviewed studies
were extracted in duplicate and reconciled where necessary
through discussion or with input from a third reviewer,
whereas data from conference proceedings and government
surveillance reports were extracted by a single reviewer. In
cases where data were unclear, we attempted to contact the
study/report the author for clariﬁcation. Where a study spanning more than one year reported data as an aggregate over
time, this single data point was assigned to the midpoint year
of the study duration. All data, including study/report characteristics and outcome data, were extracted using a standardized extraction form (Supplemental Appendix 2).
Analysis. Five main summary measures were derived from
the extracted data and used in our analyses, stratiﬁed by typhoid and paratyphoid where applicable:
1. Incidence, deﬁned as the number of typhoid or paratyphoid
fever cases reported through a notiﬁcation system per
100,000 people in the general population
2. Prevalence, deﬁned as the number of positive typhoid or
paratyphoid cultures as a proportion of the total number of
blood samples tested from laboratory surveillance, ambulatory, or hospitalized patients
3. Ileal perforation morbidity, deﬁned as the number of typhoid perforation cases as a proportion of the total number
of typhoid cases
4. Case fatality rate, deﬁned as the number of deaths due to
typhoid or paratyphoid fever out of the total number of typhoid or paratyphoid cases
5. Perforation fatality rate, deﬁned as the number of deaths
from typhoid ileal perforation as a proportion of the total
number of typhoid ileal perforations
Annual summary measures were tabulated and plotted,
stratiﬁed by World Bank regions (East Asia and Paciﬁc, Europe
and Central Asia, South Asia, Middle East and North Africa,

sub-Saharan Africa, North America, and Latin America and the
Caribbean)9 and source population type, and 95% conﬁdence
intervals (CIs) were calculated for all measures, except the
crude incidence rate.
RESULTS
Study selection. Our search strategy identiﬁed 5,563
unique records (Figure 2). Of these, 1978 were assessed as
potentially relevant through title and abstract screening, and
their full-text reports were retrieved for further assessment
of study eligibility. A total of 219 records met the review
eligibility criteria, including 98 peer-reviewed studies, 115
government surveillance reports, and six conference
proceedings.
Study characteristics. Characteristics of the 104 included
studies and conference proceedings are shown in Table 1,
with the list and citations of the included studies presented in
Supplemental Appendix 3. Nearly all studies (91%) reported
outcomes for S. Typhi, with 30% reporting estimates for S.
Paratyphi A. Only two (2%) of the included studies reported
exclusively paratyphoid outcomes. Outcomes for S. Paratyphi
B and C were less frequently reported at 8% and 2%, respectively. Although our search strategy and inclusion criteria
were broad and inclusive with respect to longitudinal data
from all countries, half of the ﬁnal literature included in our
analysis came from only six countries: India, Bangladesh,
Pakistan, Nepal, Nigeria, and the United States. National
surveillance data were available from only 29 countries, with
subnational studies within the general population found from
12 countries, and patient-focused studies (either hospitalized
or ambulatory) from 31 countries.
The frequency of typhoidal Salmonella (either incidence or
prevalence) was reported in the majority of studies (84%) with
typhoid fever mortality, ileal perforation morbidity, and perforation mortality being reported in 17%, 7%, and 5% of studies,
respectively. Outcomes were rarely stratiﬁed by age and
gender. In addition, studies did not commonly report on
whether participants were located in urban or rural localities
(fewer than 50%), and as a result, no subgroup analyses were
possible.
Typhoid incidence trends in the general population,
by region. South Asia. We found few government surveillance
reports from South Asia that met our eligibility criteria, with
longitudinal country-level estimate available only for Nepal
and Sri Lanka (Figure 3). Recent data over a 4-year period from
Nepal showed a slight decline in typhoid incidence, from 40
cases per 100,000 population in 2010 to 35 cases in 2015;
however, incidences have consistently remained within a
small range without exhibiting too much variation. Similarly, in
Sri Lanka, but where incidence was lower, the number of typhoid cases per 100,000 population decreased from 9.5 in
2005 to 3.5 in 2014. For other South Asian countries, subnational estimates of typhoid incidence in the general population were available from studies in Pakistan, India, and
Bangladesh. These trends showed considerable variation
ranging from more than 400 cases per 100,000 in 2003 in
Karachi, Pakistan, to around 10 cases per 100,000 in Chandigarh, India. However, given the scarcity of time series data
from these subnational reasons, these estimates cannot be
extrapolated beyond the catchment areas stated in their respective studies.
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FIGURE 2. Study ﬂow chart. The preferred reporting items for systematic reviews and meta-analyses ﬂow diagram depicting the movement of
records through each stage of the systematic review.

Sub-Saharan Africa. National surveillance data from Mauritius and South Africa showed low, relatively stable incidence
over time, from 0.1 to 0.6 cases per 100,000 population between 1997 and 2004 in Mauritius, and from 0.1 to 0.3 cases
2003–2014 in South Africa (Figure 4). A steady increase in
typhoid incidence was seen over time in Ghana, however, with
60 cases per 100,000 population in 2000 and 400 cases by
2008 based on data obtained from surveillance reports. Data
on general population incidence trends in other countries in
the region were available from studies in Kiliﬁ, Kenya, and

Blantyre, Malawi. Incidence in Kiliﬁ remained relatively constant between 1998 and 2014 at about one case per 100,000
population, with a spike in 2007–2008 to approximately 3.5
cases per 100,000 population. In Blantyre, Malawi, incidence
increased sharply between 2010 and 2013, from a relatively
stable incidence of about ﬁve cases per 100,000 population
over the previous decade, to 200 cases per 100,000 population in 2013.
East Asia and Paciﬁc. National surveillance data were
available from nine countries and additional estimates were

TABLE 1
Study characteristics

Outcomes reported

Organisms isolated

Population type

Incidence
Perforation morbidity
Mortality
Perforation mortality
S. Typhi
S. Paratyphi A
S. Paratyphi B
S. Paratyphi C
General population surveillance
Hospitalized patients
Ambulatory patients
Laboratory studies

North America

Latin America
and Caribbean

Europe and
Central Asia

Middle East
and North Africa

Sub-Saharan
Africa

South Asia

East Asia
and Paciﬁc

0
0
1
0
1
0
0
0
3
1
0
0

0
0
0
0
0
0
0
0
0
0
0
0

2
1
1
1
3
0
1
0
1
3
0
0

3
1
3
0
4
1
0
0
1
3
0
1

28
2
5
4
34
3
1
1
1
21
9
5

34
2
4
0
36
22
5
1
6
13
17
10

11
1
3
0
13
4
1
0
4
6
7
1

S. Paratyphi = Salmonella enterica serotype Paratyphi; S. Typhi = Salmonella enterica serotype Typhi. Table showing metadata for all included peer-reviewed studies identiﬁed through the
database search.
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FIGURE 3. South Asia general population Salmonella enterica serotype Typhi (S. Typhi) incidence estimates. Line graphs showing the crude
incidence estimates per 100,000 per year for countries in South Asia from 2003 to 2014.

available from research studies in four countries, with considerable variability in both the level and trend in typhoid incidence
by country. Estimates from HICs such as Australia, Japan, New
Zealand, Singapore, South Korea, and Taiwan remained consistently low at less than one case per 100,000 population beginning in 1990 (Figure 5). Data from upper middle-income
countries such as China, Fiji, Malaysia, Thailand, and Tonga
showed the greatest variation, with Malaysia and Thailand
exhibiting declining trends from 4.46 cases per 100,000 in 1995 to
1.74 cases in 2003 and 8.44 in 2003 to 2.92 cases per 100,000
population in 2014, respectively. Conversely, incidences from
Fiji consistently remained greater than 40 cases per 100,000,

whereas subnational estimates from China ranged from as low
as 10 per 100,000 in 2004 in Guangxi Province to 1,850 cases
per 100,000 population in 2006 in Hongta district. In lower
middle-income countries such as Indonesia, countrywide incidence during the study period increased from 126 cases per
100,000 population in 1995 to 275 in 2005. An increase in
typhoid incidence was also observed in Cambodia, from 59
cases per 100,000 in 2006 to 112 in 2011.
Middle East and North Africa. In this region, national surveillance data from government reports were available for ﬁve
countries, with Israel, Iran, Bahrain, and Qatar showing similar
decreasing trends over time, and Iraq showing a general

FIGURE 4. Sub-Saharan Africa general population Salmonella enterica serotype Typhi (S. Typhi) incidence estimates [log scale]. Line graphs on
the logarithmic scale showing the crude incidence estimates per 100,000 per year for countries in sub-Saharan Africa from 1997 to 2014.
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FIGURE 5. East Asia and Paciﬁc general population Salmonella enterica serotype Typhi (S. Typhi) incidence estimates [log scale]. Line graphs on
the logarithmic scale showing the crude incidence estimates per 100,000 per year for countries in East Asia and the Paciﬁc from 1947 to 2014.

increase since 1994 and a peak of 196 cases per 100,000
population in 2001 (Figure 6).
Latin America and Caribbean. Government surveillance
data were available for Chile from 1975 to 2014 and for Cuba
from 1990 to 2015. Data from Chile show a steadily decreasing trend from 121 per 100,000 population in 1978 to
0.4 per 100,000 population in 2014. A series of vaccine trials
conducted in schoolchildren in various regions in Santiago,
Chile, in the 1980s also showed decreasing typhoid trends in

the untreated arms during follow-up. Incidence was consistently low during the surveillance period in Cuba, with a peak
of 2.3 cases per 100,000 population in 1993 and no cases
since 2007 (Supplemental Appendix 4.1).
Europe and Central Asia. Countrywide incidence data were
available over time for only the Netherlands (1995–2006) and
Germany (2001–2014), and for a single time point for Finland
(2003), with all estimates consistently less than 0.4 cases per
100,000 population. The single available estimate from North

FIGURE 6. Middle East and North Africa general population S. Typhi incidence estimates [log scale]. Line graphs on the logarithmic scale showing
the crude incidence estimates per 100,000 per year for countries in Middle East and North Africa from 1951 to 2013.
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FIGURE 7. Typhoid and paratyphoid case fatality rates, by region. Case fatality rates due to typhoid and paratyphoid fever as diagnosed by blood
culture in hospitalized and ambulatory populations for all regions. Rates are shown as a percentage along with 95% conﬁdence intervals. Null values
refer to studies where mortality estimates were provided with no sample size.

Jutland in Denmark in 2003 indicated 0.1 case per 100,000
population, whereas subnational data over time from Madrid
in Spain showed a low and consistently declining incidence
from the late 1990s to 0.2 cases per 100,000 population by
2005 (Supplemental Appendix 4.2).
North America. Published literature from the United States
showed a large decreasing trend from 50 cases per 100,000
population nationally in 1918 to 0.2 per 100,000 population in
1983, mirrored by subnational estimates from New Orleans
between 1930 and 1945. Countrywide data from Canada
yielded only a single estimate for 2003, at 0.4 cases per
100,000 population (Supplemental Appendix 4.3).
Paratyphoid incidence trends in the general population.
Compared with typhoid fever, there were limited eligible
studies or government surveillance reports that provided data
on paratyphoid fever incidence (Supplemental Appendix 4.4).
The most common serovar reported was S. Paratyphi A, followed by S. Paratyphi B and S. Paratyphi C. General population incidence of paratyphoid reported in eligible studies
and government surveillance reports over time in South Asia
and the East Asia and Paciﬁc region showed an overall increasing trend in paratyphoid fever, whereas Europe and
Central Asia and Latin America and the Caribbean showed an
overall decreasing trend. Regional trends from Middle East
and North Africa for 1995–2013 showed a marginally decreasing trend and low rate of paratyphoid fever, with the incidence never climbing higher than 1.3 per 100,000 people in
any country. The widest range of incidence rates of paratyphoid among all regions was observed in Latin America and
the Caribbean, ranging from 0 to 770 cases per 100,000
spanning from 1983 to 1987. The lowest regional incidence
rates were observed in Europe and Central Asia, with all reported incidence rates being lower than 0.1 cases per 100,000

between 2001 and 2014. No incidence data were retrieved
from eligible studies or reports for countries in sub-Saharan
Africa or North America.
Trends in typhoid prevalence. Eligible studies from South
Asia included data from Bangladesh, India, Nepal, and Pakistan, with much variability between and within countries
(Supplemental Appendix 5.1). There were insufﬁcient data
from the region as a whole. This, paired with the heterogeneity
in the time periods, patient characteristics and study locations
meant that no pooled regional or national estimates could be
calculated. The trend data presented here show generally
higher prevalence estimates (ranging from 4% to 37%) in the
hospitalized patient population compared with the ambulatory
or laboratory surveillance groups, although this can partially
be explained by the small sample sizes in this study. The
highest prevalences and the largest degree of variability were
generally present in the included studies from India followed
by Nepal.
In sub-Saharan Africa, typhoid data came mostly from
hospitalized patients, followed by ambulatory patients and
laboratory isolates, and covered 14 countries (Supplemental
Appendix 5.2). Countrywide estimates were available from
Uganda (1996–2007), Kenya (2006–2009), the Democratic
Republic of the Congo (2007–2011), and Ghana (2010–2013).
Outside of Nigeria, the prevalence of blood culture–proven S.
Typhi remained less than 10%. Time series data, which are
generally rare, from Blantyre in Malawi showed prevalence
rates that remained close to 1% between 1998 and 2010
before starting to exhibit an upward trend in the following
years, leading to a prevalence of 5.72% (95% CI: 5.33, 6.11) in
2013.
Most of the eligible studies from East Asia and Paciﬁc analyzed samples from hospitalized populations, followed by
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ambulatory patients and laboratory studies. The eligible
studies reported wide variation in S. Typhi positivity rates
between countries and over time, ranging from 0.05% among
ambulatory patients in Thailand in 2007 to 24.1% among
ambulatory patients in Cambodia in 2009. Data were available
from six countries in this region, including countrywide estimates from Hong Kong and Thailand (Supplemental Appendix
5.3). Subnational estimates showed considerable variation
with the trend from Tagbilaran City in the Philippines, showing
a generally decreasing trend from 1994 to 1997, whereas
subnational data from Songkhla, Thailand, rose from 4% to
10.2% in 2011 within a year due to an outbreak.
Studies from the Middle East and North Africa reported
prevalence rates mostly from laboratory studies. Serial data
from one study in Kuwait covering 1995–2002 reported relatively low rates of typhoid over time, with the percent positivity
remaining less than 4% (Supplemental Appendix 5.4). Additional aggregate estimates from Saudi Arabia in the early
1980s reported a prevalence of 6.5% (95% CI: 0.3, 12.6).
Estimates from Europe and Central Asia were available from
Georgia and Turkey only from hospitalized patients
(Supplemental Appendix 5.5). Given that one of the two
available estimates (Turkey) was from a pediatric population,
no meaningful trend could be discerned for this region.
Trends in paratyphoid prevalence. The organism most
commonly reported on was S. Paratyphi A, followed by B and
C. Eligible studies from three countries within South Asia
presented paratyphoid data and were included in this review
(Supplemental Appendix 5.6). Eligible studies from India reported primarily on S. Paratyphi A, mostly from subnational
studies of laboratory specimens but also among ambulatory
and hospitalized patients. Estimates of S. Paratyphi A prevalence were generally less than 8% across study sites and
populations and over time, except in Coimbatore (32% among
ambulatory patients in 2004). Only two studies reported on S.
Paratyphi B, from Coimbatore (1.05% in 2003 and 1.75% in
2004) and Delhi (0.01% for the period 2010–2012), both
among ambulatory patients. The longest time series from the
region spans 1993–2003 in a study from Kathmandu, Nepal,
and across all six included studies from Kathmandu, S. Paratyphi A prevalence among ambulatory patients ranged from
less than 1% in 2003 to 8% in 2010. Five studies from Pakistan
reported on S. Paratyphi A prevalence, with three of these also
reporting on S. Paratyphi B. Prevalence rates for both
remained less than 4% across study sites and over time, with
the exception of one study in Karachi that reported an S.
Paratyphi A rate of 15% for the period 2008–2010.
In subnational studies from Burkina Faso, Ghana, GuineaBissau, Kenya, Madagascar, Mozambique, Tanzania, and
Senegal, Salmonella Paratyphi A, B, and C prevalence rates
were estimated at less than 0.7% over each study period.
In East Asia and Paciﬁc countries, data on paratyphoid were
available from studies on hospitalized patients, ambulatory
patients, or laboratory specimens from Cambodia, Hong
Kong, and the Philippines. Data representative of the whole of
Hong Kong were available for the period 1984–1989 for S.
Paratyphi A and B, with prevalence estimated at 0.3% and
4.9%, respectively. S. Paratyphi A positivity was estimated at
less than 1.9% among study populations in Cambodia and the
Philippines over each study period.
Finally, only one study from the Middle East and North Africa
region that met the review inclusion criteria reported on

paratyphoid rates. In Kuwait, S. Paratyphi A prevalence based
on laboratory specimens ranged from 0.11% to 0.82% across
the period 1995–2002.
Secondary outcomes. Trends in typhoid ileal perforation
rates. Typhoid ileal perforation could not be segregated by
region because of the small number of studies (N = 7) reporting
this outcome (Supplemental Appendix 6.1). The ileal perforation rate ranged from 0% to 60%; however, discounting outliers, most of the studies reported perforation rates between
0% and 4%.
Trends in typhoid and paratyphoid death rates. Case fatality
rates varied considerably across geography, time, and organism within the studies included in this review, with 0% case
fatality being the most commonly reported estimate, and the
highest being 14.3% fatality among a small number of cases
from a study in Vientiane, Laos, between 2006 and 2010
(Supplemental Appendix 6.2). Countrywide historical mortality
data were only available from Singapore, where the case fatality rate showed a decreasing trend from 1947 to 1954.
Studies that reported typhoid perforation–related deaths had
small sample sizes ranging from 14 to 75 (Supplemental
Appendix 6.3). Studies with relatively large sample sizes
(greater than 50) reported perforation case fatality rates between 20% and 34%, with very large CIs.
DISCUSSION
Summary of results. Our review of trends in culture-proven
typhoidal Salmonella from the global literature presents a
mixed picture with broad declines reported in many regions
and settings but with large gaps in surveillance and published
data. For example, despite the fact that most countries in subSaharan Africa are endemic for typhoid fever, the prevalence
of this disease in the region is poorly deﬁned in existing literature and could reﬂect the paucity of robust reporting systems
and population-based research in this area. These gaps
highlight the need for standard notiﬁcation systems across
countries to better characterize the global burden of typhoid
and paratyphoid fever. Regional trends show generally high
incidence rates in South Asia, sub-Saharan Africa, and East
Asia and Paciﬁc where typhoid and paratyphoid fever are
endemic diseases in many countries. Regions such as North
America and Europe and Central Asia reported higher rates of
typhoid and paratyphoid fever historically with a decreasing
trend over time. Presently, most of the newly diagnosed cases
of typhoid and paratyphoid fever in these regions are imported
through travel from endemic areas/populations. Most of the
included literature reported data on typhoid fever outcomes
with paratyphoid fever being relatively underrepresented. This
is particularly interesting, given the inverse trends observed in
certain regions with paratyphoid fever incidence increasing
over time as typhoid fever incidence decreased.
Signiﬁcant increases have been reported in certain countries but should be explored in the context of long-term trends
and underlying at-risk populations. For example, surveillance
data from Cambodia (2005–2011) report increases in typhoid
and paratyphoid fever cases with published data from ambulatory populations, suggesting a higher prevalence of typhoid than in neighboring countries.10–15 On the other hand,
surveillance from Indonesia (from the mid-1990s to the
mid-2000s) also depicted an increasing trend in contrast to
the data from peer-reviewed studies that showed a relatively
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low prevalence of typhoid and paratyphoid fever in ambulatory
patients.16 Our review highlights the large variability in typhoid
and paratyphoid fever incidence and prevalence data, and while
regional summation is reasonable, there is insufﬁcient highquality data to comment on national and subnational trends.
Prevalence of comorbidities such as HIV, differences in
antimicrobial resistance patterns, over-the-counter antibiotic
availability, substandard antibiotic preparations, lack of pipeborne potable water, health system functionality, and healthseeking behaviors all weigh into the differences seen in
disease spectrum, complications, and mortality across regions.17 In addition, reports suggest considerable inﬂuence of
age, with some studies documenting increased morbidity and
mortality in younger children,18–21 whereas others report
comparatively better outcomes in this age group. The emergence of and subsequent increasing trend in single- and
multidrug-resistant typhoidal Salmonella18,19 have been associated with reported changes in disease severity.22–24 This
has narrowed the therapeutic options in high-burden countries and has also led to increased treatment costs, severity of
illness, and higher case fatality rates.22,25–28
Limitations and gaps in knowledge. Our review was limited by the availability and quality of data in the published
literature. Although we included estimates that ﬁt our inclusion
criteria where possible, meaningful trends or clustering was
not readily evident. The main reason for this is the heterogeneity in the reporting of typhoid and paratyphoid fever research. There was a notable amount of variation in testing
methodologies in the published included literature. Presently,
blood cultures are the gold standard for diagnosing typhoid,
but only 40% of extracted studies reported estimates based
on this test method and were used for our analysis. In addition,
data from government reports were included regardless of the
diagnostic method used. This exception was made because
these reports tended to be nationally representative and
would provide a more accurate picture of population-level
disease burden as opposed to estimates that only apply to the
catchment areas of hospitals and clinics.
Inconsistency in testing methodology and limited studies
reporting time series data rendered robust statistical analysis
difﬁcult. Laboratory samples were not always restricted to one
sample per patient and data on blood culture volumes were
not available. Thus, the blood culture–proven ﬁgures and rates
could well represent underestimates due to poor sensitivity of
small volume of blood cultures and varying methodologies.29
In addition, restricting the results to only include blood
culture–conﬁrmed estimates introduces selection bias because only institutions where the resources necessary to
perform sophisticated laboratory tests were included. Given
that typhoid fever more commonly occurs in resource limited
settings, this inclusion criterion could have led to further underestimation of disease burden. The diversity encountered in
incidence estimates due to the use of nonstandardized test
methods, as well as the poor sensitivity of blood cultures
highlights the need for establishing a common test methodology for global typhoid and paratyphoid fever estimates.
Roughly, half of the published data on typhoidal Salmonella
did not present age-stratiﬁed data. This makes it difﬁcult to
explore reports that school-aged children are at much higher
risk of infection with typhoidal Salmonella than children less
than 5 years of age.29 Furthermore, the importance of agestratiﬁed trends is highlighted by evidence that the average

age of typhoid infection is lower in areas of higher incidence.30
Included studies generally reported incidence data as diagnosed by local hospitals, laboratories, and institutions, and
hence may not be nationally representative. Furthermore,
subnational hospital/clinic-based estimates generally only
apply to very speciﬁc populations living under very ﬁxed
conditions; hence, these results cannot be extrapolated to the
country or provincial/state level in most cases. This further
strengthened the basis for undertaking more robust national
case studies using best possible laboratory sources of
culture-conﬁrmed typhoid cases.
It is important to note that this review could have been affected by publication bias. Certain authors published multiple
articles at different times that reported on the same population
(e.g., vaccine trial follow-ups). In such cases, the studies were
assessed for quality, and only estimates from the study reporting
more complete and recent data were kept. Because of logistical
constraints, we were unable to undertake full-text screening and
data extraction from non-English studies that were otherwise
eligible. This may have limited our results from China and Taiwan,
where a large body of medical literature exists in Mandarin. From
the initial set of studies that were determined to be relevant for
this review, close to 60% had to be excluded for a variety of
reasons (nonblood culture–conﬁrmed diagnoses, data on special populations, etc.) As a result, the estimates presented here
might not reﬂect the true burden of disease in the included settings. Only 14 studies reported on data collected at the same
location over multiple consecutive years. These studies varied in
terms of the type of population (hospitalized patients, outpatients, or laboratory samples) and were often very speciﬁc to a
clinic or hospital. For this reason, we chose to not report on such
studies separately, although our initial aim was to present them
as a separate analysis. Furthermore, certain countries (such as
India, Nigeria, and the United States) represent a sizeable portion
of the included studies. As a result, an estimate of the true GBD
could not be presented, given the dearth of systematic data from
most endemic countries.
CONCLUSION
Our systematic review suggests that although typhoid incidence has decreased in most developed countries, it remains
prevalent in many LMICs. There was reduction in the rates of
typhoid with evidence of rates having stabilized to low levels of
endemicity in some countries and virtual disappearance of the
disorder in others as a public health problem such as in Vietnam
and Thailand. To assess in depth the status on trends and
determinants, further country-based analysis using mixed
methods might provide greater insight into trends of typhoid
and factors associated with change.
The diagnosis of typhoid and paratyphoid fever can often be
under- or overestimated depending on the test methods, highlighting the need for the establishment of an accurate standard
diagnosis tool. At present, no vaccines exist for paratyphoid
fever which likely plays an important role in the relative increase
in the proportion of these isolates as rates of typhoid fever have
reduced. Further research is needed to understand the risk
factors and epidemiology of paratyphoid fever and its control.
Our report provides a comprehensive picture of the burden
of typhoid and paratyphoid fever around the world. We aimed
to be inclusive with data collection and chose to present our
results as a narrative as opposed to a meta-analysis to
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highlight the variability in typhoid and paratyphoid fever
reporting. This review can be a guiding tool for policy-makers
and academics as it summarizes the current state of typhoid
research and highlights important knowledge gaps that need
to be explored. Further mathematical modeling of clinical and
surveillance data on typhoidal Salmonella should be pursued.
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